Concise review: Mesenchymal stem cell tumor-homing: Detection methods in disease model systems

Stem Cells

Volumn 29, Issue 6, 2011, Pages 920-927

  Reagan, Michaela R ^a   Kaplan, David L ^a  

^a Tufts University   (United States)

Author keywords

Animal models; Diagnostic imaging; Disease models; Mesenchymal stem cells; Neoplasm metastasis; Neoplasms

Indexed keywords

8 QUINOLINOL INDIUM IN 111; 9 (4 FLUORO 3 HYDROXYMETHYLBUTYL)GUANINE F 18; GALLIUM 67; INDIUM 111; IODINE 123; IODINE 124; PERTECHNETIC ACID TC 99M; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BIOLUMINESCENCE; BREAST CARCINOMA; CANCER CELL; CANCER INHIBITION; CANCER THERAPY; CELL HOMING; CELL MIGRATION; CELL TRACKING; COLON CARCINOMA; DNA MODIFICATION; FLUORESCENCE IMAGING; GLIOMA; HUMAN; LUNG CARCINOMA; LUNG METASTASIS; MESENCHYMAL STEM CELL; METASTASIS; METHODOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; REGENERATIVE MEDICINE; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; TUMOR DIAGNOSIS; TUMOR MODEL; WHOLE BODY MRI;

ANIMALS; CELL MOVEMENT; CELL TRACKING; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; GENETIC ENGINEERING; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NEOPLASM METASTASIS; NEOPLASMS; TUMOR MICROENVIRONMENT;

ANIMALIA;

EID: 79957617918     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.645     Document Type: Short Survey

References (61)

1. Zhang X, Hirai M, Cantero S et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: Reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 2011;112:1206-1218.
2. Liang L, Dong C, Chen X et al. Human umbilical cord mesenchymal stem cells ameliorate mice TNBS-induced colitis. Cell Transplant 2011 (in press).
3. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317.
4. Phinney DG, Prockop DJ. Concise review: Mesenchymal stem/multi-potent stromal cells: The state of transdifferentiation and modes of tissue repair - Current views. Stem Cells 2007;25:2896-2902. (Pubitemid 350127874)
5. 18F]-FHBG. Nat Protoc 2006;1:3069-3075.
6. Chiu RCJ. "Stealth immune tolerance" in stem cell transplantation: Potential for "universal donors" in myocardial regenerative therapy. J Heart Lung Transplant 2005;24:511-516.
7. Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005;65:3307-3318. (Pubitemid 40524615)
8. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-563. (Pubitemid 47525152)
9. Liu S, Ginestier C, Ou SJ et al. Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 2011;71:614-624.
10. Goldstein RH, Reagan MR, Anderson K et al. Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res 2010;70:10044-10050.
11. Hung S-C, Deng W-P, Yang WK et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005;11:7749-7756. (Pubitemid 41611618)
12. Komarova S, Roth J, Alvarez R et al. Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor. J Ovarian Res 2010;3:12.
13. Loebinger MR, Kyrtatos PG, Turmaine M et al. Magnetic resonance imaging of mesenchymal stem cells homing to pulmonary metastases using biocompatible magnetic nanoparticles. Cancer Res 2009;69:8862-8867.
14. Xin H, Sun R, Kanehira M et al. Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors. Mol Med15:321-327.
15. Gao H, Priebe W, Glod J et al. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 2009;27:857-865.
16. Klopp AH, Spaeth EL, Dembinski JL et al. Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment. Cancer Res 2007;67:11687-11695.
17. Djouad F, Plence P, Bony C et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Stem Cells 2003;102:3837-3844. (Pubitemid 37409409)
18. Ramasamy R, Lam EW-F, Soeiro I et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: Impact on in vivo tumor growth. Leukemia 2007;21:304-310. (Pubitemid 46158124)
19. Martin FT, Dwyer RM, Kelly J et al. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: Stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res Treat 2010;124:317-326.
20. Corcoran KE, Trzaska KA, Fernandes H et al. Mesenchymal stem cells in early entry of breast cancer into bone marrow. PloS One 2008;3:e2563.
21. Bexell D, Gunnarsson S, Tormin A et al. Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 2009;17:183-190.
22. Khakoo AY, Pati S, Anderson SA et al. Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 2006;203:1235-1247. (Pubitemid 43736593)
23. Sun B, Roh K-H, Park J-R et al. Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model. Cytotherapy 2009;11:289-298, 1 p following 298.
24. Ohlsson L. Mesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrix. Exp Mol Pathol 2003;75:248-255. (Pubitemid 37373711)
25. Qiao L, Xu Z-L, Zhao T-J et al. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling. Cancer Lett 2008;269:67-77.
26. Loebinger MR, Eddaoudi A, Davies D et al. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res 2009;69:4134-4142.
27. Studeny M, Marini FC, Champlin RE et al. Advances in brief bone marrow-derived mesenchymal stem cells as vehicles for interferon-gamma delivery into tumors 1. Cancer Treat Res 2002;62:3603-3608. (Pubitemid 34728832)
28. Wang N, Fallavollita L, Nguyen L et al. Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases. Mol Ther 2009;17:1241-1249.
29. Porada CD, Almeida-Porada G. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 2010;62:1156-1166.
30. Svetlana Komarova JR. Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor. J Ovarian Res 2010;3:12.
31. Becker KL. Principles and Practice of Endocrinology and Metabolism. Philadelphia: Lippincott Williams & Wilkins, 2001.
32. Anon. Viral vector generation, Molecular biology services, cDNA libraries, cloning shRNA, Adenovirus amplification, Adenovirus purification, Transgenic animal generation, Recombinant lentiviral vector construction. Available at: http://www.nitanbiotech.com/viralvectors. php. Accessed January 19, 2011.
33. Shakhbazau AV, Sevyaryn IN, Goncharova NV et al. Viral vectors for stable transduction of human mesenchymal stem cells: Systems based on adeno-associated viruses and lentiviruses. Bull Exp Biol Med 2009;146:531-533.
34. Mátrai J, Chuah MKL, VandenDriessche T. Recent advances in lenti-viral vector development and applications. Mol Ther 2010;18:477-490.
35. Ankrum J, Karp JM. Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med 2010;16:203-209.
36. Wang H, Cao F, De A et al. Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging. Stem Cells 2009;27:1548-1558.
37. Kraitchman DL, Tatsumi M, Gilson WD et al. Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 2005;112:1451-1461. (Pubitemid 41291771)
38. de Vries IJ, Lesterhuis WJ, Barentsz JO et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005;23:1407-1413. (Pubitemid 41679393)
39. Webb GA, Hoehn M, Himmelreich U. In vivo molecular MR imaging: Potential and limit. In: Webb GA, ed. Modern Magnetic Resonance. Dordrecht, Netherlands: Springer, 2006: 1087-1098.
40. Rodriguez-Porcel M. In vivo imaging and monitoring of transplanted stem cells: clinical applications. Curr Cardiol Rep 2010;12:51-58.
41. Palestro CJ, Love C, Bhargava KK. Labeled leukocyte imaging: Current status and future directions. Q J Nucl Med Mol Imaging 2009;53:105-123.
42. Patel D, Kell A, Simard B et al. The cell labeling efficacy, cytotoxicity and relaxivity of copper-activated MRI/PET imaging contrast agents. Biomaterials 2011;32:1167-1176.
43. Kim J-B, Urban K, Cochran E et al. Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PloS One 2010;5:e9364.
44. Anderson SA, Glod J, Arbab AS et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005;105:420-425. (Pubitemid 40053114)
45. Budde MD, Frank JA. Magnetic tagging of therapeutic cells for MRI. J Nucl Med 2009;50:171-174.
46. Naumova AV, Reinecke H, Yarnykh V et al. Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging 2010;9:201-210.
47. Campan M, Lionetti V, Aquaro GD et al. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5T cardiac MRI in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol 2011 (in press).
48. Seppenwoolde J-H, Viergever MA, Bakker CJG. Passive tracking exploiting local signal conservation: The white marker phenomenon. Magn Res Med 2003;50:784-790. (Pubitemid 37187844)
49. Rad AM, Iskander ASM, Janic B et al. AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: A preliminary study. BMC Biotechnol 2009;9:28.
50. 18F-FHBG PET in a patient with glioma. Nat Clin Pract Oncol 2009;6:53-58.
51. Bulte JWM. In vivo MRI cell tracking: Clinical studies. AJR Am J Roentgenol 2009;193:314-325.
52. Wernick MN, Aarsvold JN. Emission Tomography: The Fundamentals of PET and SPECT. London: Elsevier Academic Press, 2004.
53. Hinds KA, Hill JM, Shapiro EM et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 2003;102:867-872. (Pubitemid 36917777)
54. Korf J, Veenma-van der Duin L, Brinkman-Medema R et al. Divalent cobalt as a label to study lymphocyte distribution using PET and SPECT. J Nucl Med 1998;39:836-841. (Pubitemid 28216734)
55. Hans-Jurgen B, Freeman LM. Clinical Nuclear Medicine. Berlin: Springer, 2007.
56. Gildehaus FJ, Haasters F, Drosse I et al. Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo. Mol Imaging Biol 2010 (in press).
57. Bindslev L, Haack-Sørensen M, Bisgaard K et al. Labelling of human mesenchymal stem cells with indium-111 for SPECT imaging: Effect on cell proliferation and differentiation. Eur J Nucl Med Mol Imaging 2006;33:1171-1177. (Pubitemid 44484473)
58. Chin BB, Nakamoto Y, Bulte JWM et al. 111In oxine labelled mesenchymal stem cell SPECT after intravenous administration in myocardial infarction. Nucl Med Commun 2003;24:1149-1154. (Pubitemid 39625401)
59. Singhal S, Nie S, Wang MD. Nanotechnology applications in surgical oncology. Annu Rev Med 2010;61:359-373.
60. Lo Celso C, Fleming HE, Wu JW et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 2009;457:92-96.
61. Pawelczyk E, Jordan EK, Balakumaran A et al. In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PloS One 2009;4:e6712.